Prevalence of Fabry Disease in Young Patients with Stroke in Argentina
| Autor: | Reisin, Ricardo C., Mazziotti, Julieta, León Cejas, Luciana, Zinnerman, Alberto, Bonardo, Pablo, Fernández Pardal, Manuel, Martínez, Alejandra, Riccio, Patricia, Ameriso, Sebastián, Bendersky, Eduardo, Nofal, Pedro, Cairola, Patricia, Jure, Lorena, Sotelo, Andrea, Rozenfeld, Paula Adriana, Ceci, Romina, Casas-Parera, Ignacio, Sánchez Luceros, Analía, AISYF Investigators |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: | |
| Popis: | Background Fabry disease (FD) is an underdiagnosed cause of stroke in young adults, but the frequency of this association is largely unknown. We estimated the prevalence of FD in a nationwide cohort of young adults who had stroke and transient ischemic attack (TIA) in Argentina. Methods This was a prospective, multicenter study of stroke and FD in young adults (18-55 years) conducted in Argentina between 2011 and 2015. Patients were enrolled if they had had a TIA or an ischemic or hemorrhagic stroke within the previous 180 days. FD was diagnosed by measuring α-galactosidase A activity (males) and through genetic studies (females). Results We enrolled 311 patients (54% men, mean age: 41 years). Ischemic events occurred in 89% of patients (80% infarcts, 9% TIA) and hemorrhagic strokes in 11%. One female (.3% of the total group, 1% of the cryptogenic ischemic strokes) had the pathogenic mutation c.888G>A/p.Met296Ile /Exon 6 on the GAL gene. Her only other manifestation of FD was angiokeratoma. Eighteen females had nonpathogenic intronic variations: c.-10C>T, c.-12G>A, or both. Two patients had the nonpathogenic mutation D313Y, while a third had the likely benign mutation S126G. Conclusions FD was identified in 1 patient (.3%) in this first Latin American study. The patient presented with a late-onset oligo-symptomatic form of the disease. A large number of nonpathogenic mutations were present in our cohort, and it is essential that they not be mistaken for pathogenic mutations to avoid unnecessary enzyme replacement treatment. Instituto de Estudios Inmunológicos y Fisiopatológicos |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|